TWST

Twist Bioscience Corporation Common Stock (TWST)

Stock · NASDAQ · Health Care

$141.16as of 8/28/2026

Active signals

High Beta54.3%
Support level
$47.77
Industry
Biotechnology: Biological Products (No Diagnostic Substances)

How Twist Bioscience Corporation Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$376.57MSG&A$246.98M (66%)Cost of Revenue$185.57M (49%)R&D$80.28M (21%)Tax$719.0K (0%)TWST

Source: 10-K filed Nov 17, 2025 · via SEC EDGAR / Finnhub

Twist Bioscience Corporation Common Stock Competitors

Chosen by industry and closest market cap.

  • TWST
    Twist Bioscience Corporation Common Stock
    $141.16
    ▼ 7.80%
    Market cap $6.84BP/E
  • QGEN
    Qiagen N.V. Common Shares
    $43.12
    ▼ 1.43%
    Market cap $8.60BP/E 22.14
    $32.53$57.82
  • CRSP
    CRISPR Therapeutics AG Common Shares
    $57.69
    ▼ 2.84%
    Market cap $4.99BP/E
    $44.12$78.48
  • KYMR
    Kymera Therapeutics Inc. Common Stock
    $118.08
    ▼ 1.79%
    Market cap $8.75BP/E
    $39.84$130.05
  • RLAY
    Relay Therapeutics Inc. Common Stock
    $18.78
    ▼ 3.30%
    Market cap $3.78BP/E
    $3.5$21.27
  • HALO
    Halozyme Therapeutics Inc. Common Stock
    $105.33
    ▼ 1.49%
    Market cap $10.17BP/E 27.63
    $61.23$109.66
  • KOD
    Kodiak Sciences Inc Common Stock
    $37.77
    ▼ 3.45%
    Market cap $2.84BP/E
    $8.29$47.84

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Institutional Ownership

March 31, 2026

Total shares held
73.97M
Total value held
$3.43B
Institutional holders
273
Top holders this quarter
  • Unknown6.37M
  • Unknown6.34M
  • Unknown5.55M
  • Unknown5.38M
  • Unknown5.27M
  • Unknown3.67M
  • Unknown2.64M
  • Unknown2.17M
  • Unknown1.89M
  • Unknown1.71M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.